The increasingly dynamic and multifaceted landscape of mRNA therapeutics is posing new regulatory and manufacturing challenges. Both startups and established biopharma companies require innovative ...

(Reuters) -Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major ‌step in strengthening the company's domestic production ...

The market for mRNA vaccines has experienced a surge fueled by the global rollout of the COVID-19 vaccines, and the potential of mRNA technology in public health opens a new frontier in medical ...

Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3 rd mRNA Process Development & Manufacturing Summit 2025 - Europe’s premier industry-focused forum dedicated ...

- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times - STONY BROOK, NY and ...

CAMBRIDGE, MA / ACCESS Newswire / November 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced the expansion of its U.S. manufacturing capabilities with the onshoring of Drug Product manufacturing ...

NAIROBI, Dec 18 (Reuters) - COVID-19 vaccine maker BioNTech (22UAy.DE), opens new tab aims to start production at its mRNA vaccine factory site in Rwanda in 2025, company officials said on Monday, the ...

SHANGHAI/SUZHOU--China’s vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new ...

A well-earned spotlight shines on mRNA vaccines, with recent Nobel prize accolades awarded to Katalin Karikó and Drew Weissman for their foundational research that enabled rapid and effective vaccine ...

Phylex Biosciences announces the first research project to develop an AI-derived mRNA nanoparticle vaccine against the Andes hantavirus, recently responsible for the infection outbreak in the cruise ...